ARWR
Arrowhead Pharmaceuticals, Inc.Healthcare$61.03
◆ Neutral
Mkt Cap: $8.55B|Float: 122.0M|SI: 9.4%|DTC: 5.1
Data as of market close Apr 2, 2026
IV Rank
15
IV Pctl
33%
HV 20d
53.9%
52W Range
$10-$77
ATR(14)
$3.29
Exp. Move
±10.4%
P/C Ratio
0.45
Earnings
May 11
GEX Positive
DEX Long
Net Put Premium
IV Low
Max Pain Below
Exp. Move Wide
Low Put/Call
ARWR Key Options Data
- IV Rank
- 15.4%
- Total GEX
- $0.00B
- Total DEX
- $1.1M
- Max Pain
- $60.00
- Expected Move
- ±10.4%
- Put/Call OI
- 0.45
- Net Premium
- $-0.2M
- Spot Price
- $61.03
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$6.33 | ±10.4% | $54.70 | $67.35 |
| 2026-05-15 | 43 | ±$11.35 | ±18.6% | $49.68 | $72.38 |
| 2026-06-18 | 77 | ±$15.60 | ±25.6% | $45.43 | $76.63 |
| 2026-09-18 | 169 | ±$28.90 | ±47.4% | $32.13 | $89.93 |
| 2027-01-15 | 288 | ±$32.00 | ±52.4% | $29.03 | $93.03 |
Explore ARWR options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.